Hypoxia Treatment Market Size, Trends & Growth Forecast 2024-2031

0
1كيلو بايت

Hypoxia Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- 

https://shorturl.at/iTO13

Global Hypoxia Treatment Market reached US$ 77.6 million in 2022 and is expected to reach US$ 134.3 million by 2030 growing with a CAGR of 7.2% during the forecast period 2024-2031.

Hypoxia treatment refers to medical interventions aimed at increasing oxygen levels in the body when tissues are deprived of adequate oxygen. Common treatments include supplemental oxygen therapy, mechanical ventilation, and medications to improve oxygen delivery. The approach depends on the underlying cause, such as respiratory diseases, high altitude, or circulatory issues. Early treatment is crucial to prevent severe complications and organ damage.

List of the Key Players in the Hypoxia Treatment Market:

CASI Pharmaceuticals Inc., Aileron Therapeutics, Inc., Lupin Pharmaceuticals, Inc., PharmaShots, Hancock Medical Inc., Hamilton Company, Spotlight Labs, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., and Merck & Co among others.

Industry Development:

On February 1, 2023, GSK announced that Jesduvroq (daprodustat), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), received approval from the U.S. Food and Drug Administration (FDA) for the once-daily treatment of anemia due to chronic kidney disease (CKD) in adults undergoing dialysis for at least four months. Jesduvroq marks the first innovative anemia treatment in over 30 years and is the only HIF-PHI approved in the U.S., offering a convenient oral option for CKD patients on dialysis.

On June 20, 2023, Akebia Therapeutics, Inc. announced that Swissmedic, the Swiss Agency for Therapeutic Products, granted marketing authorization for Vafseo (vadadustat), an oral HIF-PH inhibitor for treating symptomatic anemia associated with CKD in adults on chronic maintenance dialysis. The approval is based on clinical data from a development program involving over 7,500 patients, including a global Phase 3 trial evaluating vadadustat for anemia management in dialysis-dependent CKD patients.

Growth Forecast Projected:

The Global Hypoxia Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Hypoxia Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Hypoxia Treatment Market:

By Type: Hypoxic Hypoxia, Hypemic Hypoxic, Histotoxic Hypoxia, Stagnant Hypoxia

By Disease Type: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Others

By End Users: Hospitals, Specialty Clinics, Others

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

إعلان مُمول
البحث
إعلان مُمول
الأقسام
إقرأ المزيد
News
China says its coast guard patrols around Taiwan islands 'beyond reproach'
China's government said on Wednesday that its coast guard patrols around a group of Taiwanese...
بواسطة Ikeji 2024-02-28 05:37:05 0 3كيلو بايت
Fitness
https://www.facebook.com/Get.ErexcelMaleEnhancementGummies/
Erexcel Male Enhancement Gummies 👇❗❗❤️Official Website❤️❗❗👇...
بواسطة imkrystalcisneros 2024-12-22 16:19:09 0 2كيلو بايت
أخرى
Leading Software Development Company in Pune – Mplussoft
In today’s digital-driven world, businesses require robust, scalable, and innovative...
بواسطة yashmehtamp8 2025-03-21 09:26:21 0 1كيلو بايت
News
GBU-57 MOP ‘Not Effective’ To Destroy Iran’s Nuclear Facility At Isfahan! Top U.S. General Says Tomahawks Used Instead
The US military did not use a GBU-57 bunker-buster Massive Ordnance Penetrator (MOP) bomb on...
بواسطة Ikeji 2025-06-28 08:48:54 0 709
Health and Wellness
Reflexology Massage – Best Massage Home Services in Dubai With Zen At Home
Dubai is a city of endless energy — fast-paced work, non-stop events, and a lifestyle that...
بواسطة Zenathome 2025-07-24 00:46:10 0 1كيلو بايت
إعلان مُمول
google-site-verification: google037b30823fc02426.html